Nu-Med Plus (NUMD) Free Cash Flow (2012 - 2025)
Nu-Med Plus (NUMD) reported Free Cash Flow of -$35054.0 for Q4 2025, down 2001.56% on a YoY basis from $1843.4 in Q4 2024, and down 207.09% sequentially from -$11415.0 in Q3 2025.
Nu-Med Plus (NUMD) Free Cash Flow (2012 - 2025) Analysis & Trends
Nu-Med Plus (NUMD) has 14 years of Free Cash Flow data on file, last reported at -$35054.0 in Q4 2025.
- For the quarter ending Q4 2025, Free Cash Flow fell 2001.56% year-over-year to -$35054.0; the trailing twelve-month figure through Dec 2025 stood at -$46469.0 (down 948.25% YoY), and the FY2025 full-year result was -$47979.0, down 982.31% from the prior year.
- Free Cash Flow retreated to -$35054.0 in Q4 2025, from -$11415.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $628.0 in Q3 2022 to a low of -$79241.0 in Q1 2021.
- A 5-year average of -$21329.5 and a median of -$18869.0 in 2023 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow surged 101.53% in 2022 and slumped 3104.62% in 2023, its largest moves.
- Tracing NUMD's Free Cash Flow over 5 years: stood at -$20165.0 in 2021, then declined by 21.17% to -$24433.0 in 2022, then soared by 82.47% to -$4282.0 in 2023, then surged by 61.05% to -$1668.0 in 2024, then plunged by 2001.56% to -$35054.0 in 2025.
- Business Quant data shows NUMD's Free Cash Flow at -$35054.0 in Q4 2025, -$11415.0 in Q3 2025, and -$1668.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | -35,054.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -35,054.00 |
| Dec 31, 2025 | -35,054.00 |
| Sep 30, 2025 | -11,415.00 |
| Sep 30, 2025 | -11,415.00 |
| Dec 31, 2024 | -1,668.00 |
| Dec 31, 2024 | -1,668.00 |
| Jun 30, 2024 | -2,315.00 |
| Jun 30, 2024 | -2,315.00 |
| Mar 31, 2024 | -450.00 |
| Mar 31, 2024 | -450.00 |
| Dec 31, 2023 | -4,282.00 |
| Dec 31, 2023 | -4,282.00 |
| Sep 30, 2023 | -18,869.00 |
| Sep 30, 2023 | -18,869.00 |
| Jun 30, 2023 | -23,072.00 |
| Jun 30, 2023 | -23,072.00 |
| Mar 31, 2023 | -20,166.00 |
| Mar 31, 2023 | -20,166.00 |
| Dec 31, 2022 | -24,433.00 |
| Dec 31, 2022 | -24,433.00 |